Ballentine Partners’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $707K | Sell |
9,842
-1,029
| -9% | -$96.9K | 0.01% | 454 |
|
|
2026
Q1 | $1.29M | Buy |
10,871
+1,425
| +15% | +$176K | 0.02% | 295 |
|
|
2025
Q4 | $1.19M | Sell |
9,446
-2,407
| -20% | -$314K | 0.02% | 290 |
|
|
2025
Q3 | $1.73M | Buy |
11,853
+276
| +2% | +$41.7K | 0.02% | 222 |
|
|
2025
Q2 | $1.81M | Sell |
11,577
-706
| -6% | -$112K | 0.03% | 209 |
|
|
2025
Q1 | $2.02M | Buy |
12,283
+132
| +1% | +$22K | 0.04% | 183 |
|
|
2024
Q4 | $1.98M | Buy |
12,151
+357
| +3% | +$63.8K | 0.03% | 177 |
|
|
2024
Q3 | $2.3M | Sell |
11,794
-2
| -0% | -$369 | 0.04% | 154 |
|
|
2024
Q2 | $2.04M | Sell |
11,796
-137
| -1% | -$22.8K | 0.04% | 154 |
|
|
2024
Q1 | $2.02M | Sell |
11,933
-107
| -0.9% | -$20K | 0.04% | 153 |
|
|
2023
Q4 | $2.38M | Buy |
12,040
+2,138
| +22% | +$378K | 0.05% | 129 |
|
|
2023
Q3 | $1.72M | Buy |
9,902
+141
| +1% | +$25.6K | 0.04% | 138 |
|
|
2023
Q2 | $1.68M | Sell |
9,761
-2,116
| -18% | -$366K | 0.04% | 137 |
|
|
2023
Q1 | $1.98M | Buy |
11,877
+2,450
| +26% | +$402K | 0.05% | 129 |
|
|
2022
Q4 | $1.38M | Buy |
9,427
+186
| +2% | +$27.5K | 0.04% | 135 |
|
|
2022
Q3 | $1.37M | Buy |
9,241
+674
| +8% | +$113K | 0.05% | 122 |
|
|
2022
Q2 | $1.47M | Buy |
8,567
+12
| +0.1% | +$2.08K | 0.05% | 121 |
|
|
2022
Q1 | $1.61M | Buy |
8,555
+22
| +0.3% | +$4.35K | 0.05% | 122 |
|
|
2021
Q4 | $2.08M | Buy |
8,533
+367
| +4% | +$80.4K | 0.06% | 106 |
|
|
2021
Q3 | $1.58M | Buy |
8,166
+25
| +0.3% | +$5.04K | 0.05% | 114 |
|
|
2021
Q2 | $1.52M | Buy |
8,141
+1,328
| +19% | +$231K | 0.05% | 114 |
|
|
2021
Q1 | $1.07M | Sell |
6,813
-199
| -3% | -$31.5K | 0.04% | 146 |
|
|
2020
Q4 | $1.16M | Sell |
7,012
-272
| -4% | -$44.2K | 0.05% | 135 |
|
|
2020
Q3 | $1.21M | Sell |
7,284
-2,278
| -24% | -$350K | 0.05% | 121 |
|
|
2020
Q2 | $1.31M | Buy |
9,562
+6,594
| +222% | +$861K | 0.06% | 112 |
|
|
2020
Q1 | $350K | Buy |
2,968
+250
| +9% | +$32.9K | 0.02% | 228 |
|
|
2019
Q4 | $360K | Buy |
2,718
+44
| +2% | +$5.47K | 0.02% | 270 |
|
|
2019
Q3 | $333K | Sell |
2,674
-81
| -3% | -$9.78K | 0.02% | 275 |
|
|
2019
Q2 | $312K | Buy |
+2,755
| New | +$289K | 0.02% | 285 |
|
|
2018
Q4 | – | Sell |
-2,213
| Closed | -$203K | – | 385 |
|
|
2018
Q3 | $203K | Buy |
+2,213
| New | +$196K | 0.01% | 338 |
|
Other funds holding ZTS
Ballentine Partners's ZTS Position: Q2 2026 in Review
Ballentine Partners reduced its Zoetis (ZTS) stake by 9.5% in Q2 2026, selling an estimated $96.9K and leaving 9,842 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #454.
Ballentine Partners first reported a position in ZTS in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.38M in Q4 2023. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Ballentine Partners held 9,842 shares of Zoetis worth $707K as of Q2 2026.
- Ballentine Partners sold 1,029 Zoetis shares in Q2 2026, an estimated $96.9K.
- Zoetis made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #454 holding.
- Ballentine Partners first reported a position in Zoetis in Q3 2018 and has held it in 30 quarters since.
- Ballentine Partners's Zoetis position peaked at $2.38M in Q4 2023.
- 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.